OSUR OraSure Technologies, Inc.
Healthcare$3.94+9.14%ClosedMarket Cap: $271.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.80
P/S
2.20
EV/EBITDA
-1.76
DCF Value
$-0.14
FCF Yield
-19.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
41.0%
Operating Margin
-64.6%
Net Margin
-66.4%
ROE
-21.5%
ROA
-19.8%
ROIC
-20.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $27.9M | 37.4% | $-23.2M | $-22.4M | $— | — |
| Q4 null | $26.8M | 41.0% | $-16.9M | $-19.3M | $— | — |
| FY null | $115.0M | 41.9% | $-68.1M | $-68.7M | $— | — |
| Q3 null | $27.1M | 43.5% | $-15.7M | $-13.7M | $— | — |
| Q2 null | $31.2M | 42.1% | $-17.3M | $-19.7M | $— | — |
| Q1 null | $29.9M | 41.1% | $-18.3M | $-16.0M | $— | — |
| Q4 null | $37.4M | 36.9% | $-11.6M | $-10.8M | $— | — |
| FY null | $185.8M | 41.0% | $-20.6M | $-19.5M | $— | — |
| Q3 null | $39.9M | 42.8% | $-5.6M | $-4.5M | $— | — |
| Q2 null | $54.3M | 47.1% | $-34.0K | $-615.0K | $— | — |
| Q1 null | $54.1M | 44.9% | $-3.4M | $-3.6M | $— | — |
| Q4 2023 | $75.9M | 47.0% | $7.7M | $20.1M | $0.27 | — |